- Home
- SION vs AMAL Comparison
SION vs AMAL Comparison
Compare SION & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SION
- AMAL
- Stock Information
- Founded
- SION 2019
- AMAL 1923
- Country
- SION United States
- AMAL United States
- Employees
- SION N/A
- AMAL N/A
- Industry
- SION
- AMAL Commercial Banks
- Sector
- SION
- AMAL Finance
- Exchange
- SION NYSE
- AMAL Nasdaq
- Market Cap
- SION 920.2M
- AMAL 937.6M
- IPO Year
- SION 2025
- AMAL 2018
- Fundamental
- Price
- SION $20.47
- AMAL $32.94
- Analyst Decision
- SION Strong Buy
- AMAL Buy
- Analyst Count
- SION 1
- AMAL 2
- Target Price
- SION $32.00
- AMAL $38.50
- AVG Volume (30 Days)
- SION 260.6K
- AMAL 197.0K
- Earning Date
- SION 08-25-2025
- AMAL 07-24-2025
- Dividend Yield
- SION N/A
- AMAL 1.68%
- EPS Growth
- SION N/A
- AMAL 9.81
- EPS
- SION N/A
- AMAL 3.36
- Revenue
- SION N/A
- AMAL $303,970,000.00
- Revenue This Year
- SION N/A
- AMAL $11.72
- Revenue Next Year
- SION N/A
- AMAL $12.48
- P/E Ratio
- SION N/A
- AMAL $9.92
- Revenue Growth
- SION N/A
- AMAL 7.13
- 52 Week Low
- SION $7.26
- AMAL $25.03
- 52 Week High
- SION $25.19
- AMAL $38.19
- Technical
- Relative Strength Index (RSI)
- SION N/A
- AMAL 63.07
- Support Level
- SION N/A
- AMAL $32.82
- Resistance Level
- SION N/A
- AMAL $33.58
- Average True Range (ATR)
- SION 0.00
- AMAL 0.69
- MACD
- SION 0.00
- AMAL 0.15
- Stochastic Oscillator
- SION 0.00
- AMAL 81.70
About SION SIONNA THERAPEUTICS INC
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.